首页 | 本学科首页   官方微博 | 高级检索  
检索        

肾细胞癌P53、c-erbB-2癌蛋白高表达与预后的关系
引用本文:赵坡,许红民,李晓瑛,王德文,毛新,李维华.肾细胞癌P53、c-erbB-2癌蛋白高表达与预后的关系[J].中华泌尿外科杂志,1995(8).
作者姓名:赵坡  许红民  李晓瑛  王德文  毛新  李维华
作者单位:北京军事医学科学院病理学教研室,解放军总医院病理科,华西医科大学精神科遗传室
摘    要:应用突变型P53、c-erbB-2抗体和微波炉抗原修复法对31例肾细胞癌进行免疫组化研究。结果显示突变型P53和c-erbB-2癌蛋白的高表达阳性率分别为35.5%和74.2%;阳性患者的5年存活率分别为27.2%和43.5%,而阴性患者的5年存活率则分别为70.0%和87.5%。提示突变型P53、c-erbB-2的高表达可能与肾细胞癌的预后有关(P<0.05),并可能成为肾细胞癌的恶性标志和预后的辅助指标之一。

关 键 词:肾肿瘤,癌,基因,预后

Overexpression of P53 and c-erbB-2 oncoprotein in the prognosis of renal cell carcinoma
Zliao Po, Xu Hongmin,Li Xiaoying,et al..Overexpression of P53 and c-erbB-2 oncoprotein in the prognosis of renal cell carcinoma[J].Chinese Journal of Urology,1995(8).
Authors:Zliao Po  Xu Hongmin  Li Xiaoying  
Abstract:We performed an immunohistochemical study in 31 cases of renal cell carcinoma(RCC)by using mutant type of P53 and cerbB-2 antibody and repairing method of antigen with microwave oven.The result showed that the positive rate for overexpression of mutant type of P53 and c-erbB-2 oncoprotein was 35.5% and 74.2% and the 5-year survival rate for the positive cases was 27.2% and 43.5%,but for the negative cases was 70.0% and 87.5% respectively.It was suggested that the overexpression of mutant type of P53 and c-erbB-2 corresponded to the prognosis in RCC (P<0.05).The overexpression of mutant type of P53 and c-erbB-2 might become one of adjunct markers for malignancy and prognosis in RCC.
Keywords:Kidney neoplasms  Carcinoma genes  Prognosis  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号